Scineuro Pharmaceuticals logo
VerifiedBiotechnology Research· Founded 2020

Scineuro Pharmaceuticals

SciNeuro Pharmaceuticals is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases. Since its founding in 2020, SciNeuro has built a portfolio of pipeline programs staged from discovery to clinical development by addressing three key disease-driving mechanisms of neurodegeneration – neurovascular inflammation, proteinopathy, and immune response. The company aims to develop disease-modifying treatment options for Alzheimer’s disease, Parkinson’s disease, and other devastating CNS diseases.

7-day free trial · no credit card

HeadquartersRockville, United StatesEmployees33(11 to 50)Founded year2020Websitescineuro.comLinkedIn profileLinkedIn

Verified contacts

26

available on Kipplo

LinkedIn employees

33

11 to 50 range

Open roles

no listings

Distinct roles

23

indexed titles

Tech stack

1

tools in use

Monthly traffic

47

organic / mo

Sign up free to see all 26 verified contacts at Scineuro Pharmaceuticals

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

26 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Scineuro Pharmaceuticals

23 distinct titles indexed · top 10 shown.

  • 2(),
  • 1& -
  • 1()
  • 1, -
  • 1,,
  • 1ascentage pharma
  • 1assistant director
  • 1associate scientist
  • 1biologic platform and discovery lead, senior scientist
  • 1board director
  • +13more titles

Sign up to unlock all 26 contacts at Scineuro Pharmaceuticals

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 26 verified contacts at Scineuro Pharmaceuticals

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Scineuro Pharmaceuticals | Kipplo Discover